Dragica Soldo-Juresa Maja Radman Vlatko Pejsa Velimir Bozikov
10.4103/0256-4947.59371
Ann Saudi Med
2010 Jan-Feb;30(1):88-9.
CC BY
https://pubmed.ncbi.nlm.nih.gov/20103968/
Angioedema / complications Erythema Infectiosum / complications Macrophage Activation Syndrome / etiology Parvovirus B19, Human / immunology Urticaria / complications Vasculitis / complications
Angioedema / complications Erythema Infectiosum / complications Macrophage Activation Syndrome / etiology Parvovirus B19, Human / immunology Urticaria / complications Vasculitis / complications Case Reports Acute Disease Adrenal Cortex Hormones / therapeutic use Anti-Inflammatory Agents / therapeutic use Antibodies, Viral / blood Anticoagulants / therapeutic use Enoxaparin / therapeutic use Female Humans Immunoglobulin G / blood Immunoglobulins, Intravenous / therapeutic use Immunologic Factors / therapeutic use Macrophage Activation Syndrome / diagnosis Macrophage Activation Syndrome / drug therapy Methylprednisolone / therapeutic use Middle Aged Plasma Adrenal Cortex Hormones Anti-Inflammatory Agents Antibodies, Viral Anticoagulants Enoxaparin Immunoglobulin G Immunoglobulins, Intravenous Immunologic Factors Methylprednisolone
PMC2850192
20103968
Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedema
2010